Mastodawn

Chicago Sun-Times - All | Illinois in line for $148.8M opioid settlement payout from Purdue Pharma by Mitchell Armentrout

AI generated summary, Read the full article for complete information.

Illinois will receive $148.8 million from Purdue Pharma and the Sackler family as part of a nationwide $7.4 billion opioid settlement, with payments spread over the next 15 years—most of it arriving in the first three years. Attorney General Kwame Raoul emphasized that the money will be allocated equitably to support addiction treatment, prevention, and recovery programs across the state, acknowledging that no sum can fully repair the damage caused by Purdue’s aggressive marketing of OxyContin. The settlement follows a 2016 federal investigation and a 2019 Illinois lawsuit; while the Sacklers are barred permanently from selling opioids in the U.S., the broader agreement requires the family to pay $1.5 billion and Purdue $900 million initially, with additional installments thereafter. Nationwide opioid settlements have exceeded $58 billion, with Illinois earmarked for $1.6 billion total, of which over $531 million has already been disbursed. The funds aim to address the ongoing opioid crisis, which has claimed roughly 725,000 U.S. lives since 1999 and saw a spike in Cook County overdoses during the COVID‑19 pandemic.

#PurduePharma #Sacklerfamily #KwameRaoul #Illinois

Illinois in line for $148.8M opioid settlement payout from Purdue Pharma

The money will be paid out for recovery and treatment programs over the next 15 years.

Chicago Sun-Times

The Bad Place Apr 29

The Guardian | Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case by Associated Press

AI generated summary, Read the full article for complete information.

Purdue Pharma, the maker of OxyContin, will be dissolved and replaced by a new publicly‑controlled company, Knoa Pharma, after a federal judge approved a sweeping legal settlement that ends criminal and civil investigations into the firm’s role in the U.S. opioid crisis. The settlement includes an $8.3 billion forfeiture, fines and penalties—of which the government will collect $225 million—while members of the Sackler family that owned Purdue will pay up to $7 billion over 15 years, most of it earmarked for government programs to combat opioid abuse. Thousands of lawsuits from states, localities, Native American tribes and individual victims were resolved, with individual payouts ranging from about $8,000 to $16,000. Victims and families testified that the deal offers little real justice, but the agreement also provides for the public release of millions of internal Purdue documents and shields the Sacklers from further lawsuits, aiming to bring closure and resources to address the epidemic.

#PurduePharma #Sacklerfamily #opioidscrisis #pharmaceuticalsindustry

Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case

OxyContin maker to be replaced by new company aiming to combat opioid crisis as legal settlement takes effect

The Guardian

The Bad Place Apr 29

News Headlines | Purdue Pharma sentenced ahead of bankruptcy

AI generated summary, Read the full article for complete information.

A U.S. federal judge criminally sentenced Purdue Pharma, the maker of OxyContin, ahead of its planned bankruptcy and dissolution, ordering the company’s board chair to apologize to victims after more than six hours of emotional testimony. The sentencing comes as Purdue and the Sackler family—its longtime owners—agree to a bankruptcy plan that will channel over $8 billion in fines, forfeitures and penalties to affected communities, while the company itself will be dissolved on May 1 and its remnants re‑formed as the public‑benefit entity Knoa Pharma, focused on opioid‑use‑disorder treatments and overdose reversal. Although many victims objected to the settlement because it shields the Sacklers from criminal prosecution, the judge deemed it the “best route” among available options and urged bankruptcy lawyers to honor compensation promises. The case underscores the broader opioid crisis, which has claimed roughly 806,000 American lives from 1999 to 2023.

#PurduePharma #Sacklerfamily #KnoaPharma #CDC #MadelineCoxArleo #SteveMiller

The Bad Place Apr 29

US Top News and Analysis | Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement

AI generated summary, Read the full article for complete information.

Purdue Pharma, the maker of OxyContin, was sentenced in New Jersey federal court to $5.5 billion in fines and penalties after its 2020 guilty plea for deceiving regulators and paying doctors kickbacks to boost opioid sales. The judgment clears the way for the company’s bankruptcy dissolution and the funding of a $7.4 billion settlement intended to compensate victims of the opioid epidemic, though most of the fine will remain unpaid with only $225 million collected by the Justice Department. During a seven‑hour hearing, over 200 victims shared personal stories of addiction and loss, urging harsher punishment and accountability for the Sackler family and executives, while Judge Madeline Cox Arleo noted the government’s failures to stop Purdue’s misconduct and expressed hope future cases would prevent corporations from treating fines as merely a cost of doing business. Victims also voiced frustration that the bankruptcy settlement’s strict documentation requirements could bar many from receiving compensation, prompting the judge to call for flexibility in handling missing prescription records. Purdue plans to emerge from bankruptcy on May 1 as a nonprofit focused on opioid‑addiction treatment and overdose‑reversal medicines, having admitted to past misbranding and fraud in marketing OxyContin as less addictive than it is.

#PurduePharma #Sacklerfamily #Federalcourt #OxyContin #MadelineCoxArleo #SteveMiller

The Bad Place Apr 29

Home - CBSNews.com | Maker of OxyContin set to dissolve after judge approves criminal sentence

AI generated summary, Read the full article for complete information.

Purdue Pharma, the maker of OxyContin, is slated to dissolve and be restructured as a public‑good company by the end of the week after a bankruptcy judge approved its criminal plea and a massive civil settlement that resolves thousands of lawsuits over the opioid crisis, which has caused more than 900,000 deaths since 1999. The agreement includes $8.3 billion in federal forfeitures, fines and penalties, with the government agreeing to accept $225 million in exchange for Purdue’s separate settlements with state, local, tribal and other plaintiffs; the Sackler family members who own the firm will contribute up to $7 billion over 15 years, and total settlement values exceed $50 billion, funding government efforts to combat opioid abuse and providing individual victims with payments of roughly $8,000‑$16,000. During the court proceedings, dozens of family members and survivors testified about the devastating loss of loved ones to OxyContin‑related addiction, urging the judge to reject the plea deal and call for full prosecution.

#PurduePharma #OxyContin #Sacklerfamily #CDC

Purdue Pharma, maker of OxyContin, set to dissolve after judge approves its criminal sentence

Purdue Pharma, the maker of OxyContin, is set to be dissolved as a massive legal settlement resolving thousands of lawsuits takes effect.

The Japan Times Apr 27

Purdue, whose painkiller OxyContin has been widely blamed for fueling the opioid crisis in the U.S., set aside about $865 million for victims, but strict paperwork requirements mean many may never be compensated. https://www.japantimes.co.jp/business/2026/04/27/companies/purdue-opioid-victims-paperwork/?utm_medium=Social&utm_source=mastodon #business #companies #pharmaceuticals #oxycontin #drugs #purduepharma #us #court #lawsuits

After waiting years for justice, Purdue opioid victims are defeated — by paperwork

Purdue's long, grinding bankruptcy wound up creating daunting hurdles for many trying to qualify for the company's compensation.

The Japan Times

The Bad Place Apr 24

Salon.com | After years of waiting, many opioid victims will be shut out of Purdue settlement by Craig R. McCoy, Bob Fernandez

AI generated summary, Read the full article for complete information.

After years of waiting, the revised $7.4 billion Purdue Pharma bankruptcy settlement—meant to compensate roughly 140,000 opioid‑victims—will leave tens of thousands without any payment, as the plan slashes benefits, tightens eligibility, eliminates the affidavit option that let claimants prove opioid use without prescriptions, and drops payouts for many families to as low as $8,000; the changes, made behind closed doors after the Supreme Court rejected the original plan, have surprised claimants who missed shifting deadlines or cannot produce old medical records, effectively shutting out a large share of those who filed claims against Purdue and its owners, the Sackler family.

#PurduePharma #Sacklerfamily #OxyContin #class-actionlawsuits #opioidcrisis #MaryJannotta #EllenIsaacs

AI generated summary, Read the full article for complete information.